DOI: 10.1023/a:1005734429304. c-erbB-2 oncoprotein, CEA, and CA 15.3 in patients with breast cancer: prognostic value

c-erbB-2 oncoprotein, CEA, and CA 15.3 in patients with breast cancer: prognostic value

10.1023/a:1005734429304

Crossref journal-article

Springer Science and Business Media LLC

Breast Cancer Research and Treatment (297)

Bibliography

Molina, R., Jo, J., Filella, X., Zanon, G., Pahisa, J., MuÃ±oz, M., Farrus, B., Latre, M. L., Escriche, C., Estape, J., & Ballesta, A. M. (1998). c-erbB-2 oncoprotein, CEA, and CA 15.3 in patients with breast cancer: prognostic value. Breast Cancer Research and Treatment, 51(2), 109â119.

Authors 11

Rafael Molina (first)
Judith Jo (additional)
Xavier Filella (additional)
Gabriel Zanon (additional)
Jaume Pahisa (additional)
Montserrat Muñoz (additional)
Blanca Farrus (additional)
Maria Luz Latre (additional)
Carmen Escriche (additional)
Jordi Estape (additional)
Antonio M. Ballesta (additional)

References 28 Referenced 86

Hilkens J, Kroezen V, Bonfrer JMG, Bruning PF, Hilgers J, van Eijkeren J: A radioimmunoassay for a new antigen (Mam-6) present in the sera of patients with metastasized carcinomas. In: Peeters H (ed) Protides of the Biological Fluids. Pergamon Press, Oxford, 1985, pp 651–653 / Protides of the Biological Fluids by J Hilkens (1985)
Kufe D, Inghirami G, Abe M, Hayes D, Justi-Wheeler H, Schlom J: Differential reactivity of a novel monoclonal antibody (DF-3) with human malignant versus benign breast tumors. Hybridoma 3: 223–232, 1984 (10.1089/hyb.1984.3.223) / Hybridoma by D Kufe (1984)
Stahli C, Takacs B, Miggiano V, Stachelin T, Carman H: Monoclonal antibodies against antigens on breast cancer cells. Experientia 41: 1377–1381, 1985 (10.1007/BF01949996) / Experientia by C Stahli (1985)
Colomer R, Ruibal A, Salvador L: Circulating tumor marker levels in advanced breast carcinoma correlate with the extent of metastatic disease. Cancer 64: 1674–1681, 1989 (10.1002/1097-0142(19891015)64:8<1674::AID-CNCR2820640820>3.0.CO;2-V) / Cancer by R Colomer (1989)
Molina R, Ballesta AM: Evaluation of several tumor markers (MCA, CA 15.3, BCM and CA 549) in tissue and serum of patients with breast cancer. In: Ceriani RL (ed) Breast Epithelial Antigens. Molecular Biology to Clinical Applications, Plenum Press, New York 1991, pp 161–168 (10.1007/978-1-4615-3740-3_15) / Breast Epithelial Antigens by R Molina (1991)
Molina R, Zanon G, Filella X, Moreno F, Jo J, Daniels M, Latre ML, Gimenez N, Pahisa J, Velasco M, Ballesta AM: Use of serial carcinoembryonic antigen and CA 15.3 assays in detecting relapses in breast cancer patients. Breast Cancer Res Treat 36: 41–48, 1995 (10.1007/BF00690183) / Breast Cancer Res Treat by R Molina (1995)
Coussens L, Yang-Feng TL, Liao YC et al.: Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with the neu oncogene. Science 230: 1130–1139, 1985 (10.1126/science.2999974) / Science by L Coussens (1985)
Molina R, Ciocca R, Tandon AK, Allred DC, Clark GC, Chamness GC, Gullick WJ, McGuire WL: Expression of HER-2/neu oncoprotein in human breast cancer. A comparison of immunohistochemical and western blot techniques. Anticancer Res 12: 1965–1972, 1992 / Anticancer Res by R Molina (1992)
Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, Ress MF: Studies of the HER-2 neu proto-oncogene in human breast and ovarian cancer. Science 244: 707–712, 1989 (10.1126/science.2470152) / Science by DJ Slamon (1989)
Tandon AK, Clark GM, Chamness GC, Ullrich A, McGuire WL: HER-2/neu oncogene protein and prognosis in breast cancer. J Clin Oncol 7: 1120–1128, 1989 (10.1200/JCO.1989.7.8.1120) / J Clin Oncol by AK Tandon (1989)
Allred DC, Clark GM, Molina R, Tandon AK, Schnitt SJ, Gilchrist KW, Osborne CK, Tormey DC, Abeloff MD, McGuire WI: Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer. Human Pathol 23: 974–979, 1992 (10.1016/0046-8177(92)90257-4) / Human Pathol by DC Allred (1992)
Berger MS, Locher GW, Saurer S et al.: Correlation of cerbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res 48: 1238–1243, 1988 / Cancer Res by MS Berger (1988)
Marx D, Schauer A, Reiche Ch et al.: c-erbB-2 expression in correlation to other biological parameters of breast cancer. J Cancer Res Clin Oncol 116: 15–20, 1990 (10.1007/BF01612634) / J Cancer Res Clin Oncol by D Marx (1990)
Molina R, Filella X, Segui MA, Climent MA, Perez-Picañol E, Alonso C, Jo J, Ojeda B, Tandon AK, Ballesta AM: Oncogenic proteins and prognostic correlations in breast cancer. In vivo 7: 585–590, 1993 / In vivo by R Molina (1993)
Allred DC, Clark GM, Tandon AK, Molina R, Tormey DC, Osborne CK, Gilchrist KW, Mansour EG, Abeloff MD, McGuire WL: HER-2/neu in node-negative breast cancer: Prognostic significance of overexpression influenced by the presence of in situ carcinoma. J Clin Oncol 4: 599–605, 1992 (10.1200/JCO.1992.10.4.599) / J Clin Oncol by DC Allred (1992)
Zabrecky JR, Lam T, McKenzie SJ, Carney W: The extracellular domain of p185 neu is released from the surface of human breast carcinoma cell, SK-BR-3. J Biol Chem 266: 1716–1720, 1991 (10.1016/S0021-9258(18)52354-1) / J Biol Chem by JR Zabrecky (1991)
Pupa SM, Menard S, Morelli D, Pozzi B, De Palo G, Colnaghi MI: The extracellular domain of the c-erbB-2 oncoprotein is released from tumor cells by proteolytic cleavage. Oncogene 8: 2917–2923, 1993 / Oncogene by SM Pupa (1993)
McKenzie SJ, De Sombre KA, Bast BS, Hollis DR, Whitaker RS, Berchuck A, Boyer CM, Bast RC: Serum levels of HER-2/neu (C-erbB-2) correlate with overexpression of p184 neu in human ovarian cancer. Cancer 71: 3942–3946, 1993 (10.1002/1097-0142(19930615)71:12<3942::AID-CNCR2820711224>3.0.CO;2-3) / Cancer by SJ McKenzie (1993)
Narita T, Funahashi H, Satoh Y, Takagi H: C-erbB-2 in the sera of breast cancer patients. Breast Cancer Res Treat 24: 97–102, 1992 (10.1007/BF01961242) / Breast Cancer Res Treat by T Narita (1992)
International Union Against Cancer (UICC): TNM classification of malignant tumours. In: Hermanek P, Soben LH (eds) 4 ed Springer Verlag, Berlin, 1987 / TNM classification of malignant tumours by International Union Against Cancer (1987)
Molina R, Jo J, Filella X, Bruix J, Castells A, Hague M, Ballesta AM: Serum levels of c-erbB-2 (HER-2/neu) in patients with malignant and non-malignant diseases. Tumour Biology 18: 188–196, 1997 (10.1159/000218029) / Tumour Biology by R Molina (1997)
Zhou DJ, Ahauja H, Cline MJ: Proto-oncogene abnormalities in human breast cancer: c-erbB-2 amplification does not correlate with recurrence of disease. Oncogene 4: 105–108, 1989 / Oncogene by DJ Zhou (1989)
Molina R, Filella X, Torres MD, Ballesta AM, Mengual P, Cases A, Balague A: SCC antigen measured in malignant and nonmalignant diseases. Clin Chem 36: 251–254, 1990 (10.1093/clinchem/36.2.251) / Clin Chem by R Molina (1990)
Molina R, Filella X, Bruix J, Mengual P, Bosch J, Calvet X, Jo J, Ballesta AM: Cancer antigen 125 in serum and ascitic fluid of patients with liver diseases. Clin Chem 37: 1379–1383, 1991 (10.1093/clinchem/37.8.1379) / Clin Chem by R Molina (1991)
Cases A, Filella X, Molina R, Ballesta AM, Lopez-Revert J, Revert L: Tumor markers in chronic renal failure and hemodialysis patients. Nephron 37: 1379–1383, 1991 / Nephron by A Cases (1991)
Ritts RE Jr, Del Villano BC, Go VLW, Heberman RB, Klug TL, Zurawski VR Jr: Initial clinical evaluation of an immunoradiometric assay for CA 19.9 using the NCI serum bank. Int J Cancer 33: 339–345, 1984 (10.1002/ijc.2910330310) / Int J Cancer by RE Ritts Jr (1984)
Leitzel K, Teramoto Y, Konrad K, Chinchilli VM, Volas G, Grossberg H, Harvey H, Demers L, Lipton A: Elevated serum c-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer. J Clin Oncol 13: 1129–1135, 1995 (10.1200/JCO.1995.13.5.1129) / J Clin Oncol by K Leitzel (1995)
Molina R, Jo J, Zanon G, Filella X, Farrus M, Muñoz M, Latre ML, Pahisa J, Velasco M, Fernandez P, Estapé J, Ballesta AM: Utility of c-erbB-2 in tissue and in serum in the early diagnosis of recurrence in breast cancer patients: comparisc with carcinoembryonic antigen and CA 15.3. Br J Cancer 74: 1126–1131, 1996 (10.1038/bjc.1996.501) / Br J Cancer by R Molina (1996)

Dates

Type	When
Created	22 years, 8 months ago (Dec. 21, 2002, 6:13 p.m.)
Deposited	2 months, 1 week ago (June 21, 2025, 12:32 a.m.)
Indexed	2 months, 1 week ago (June 22, 2025, 12:02 a.m.)
Issued	26 years, 11 months ago (Sept. 1, 1998)
Published	26 years, 11 months ago (Sept. 1, 1998)
Published Print	26 years, 11 months ago (Sept. 1, 1998)

Funders 0

None

BibTeX

@article{Molina_1998, title={c-erbB-2 oncoprotein, CEA, and CA 15.3 in patients with breast cancer: prognostic value}, volume={51}, ISSN={1573-7217}, url={http://dx.doi.org/10.1023/a:1005734429304}, DOI={10.1023/a:1005734429304}, number={2}, journal={Breast Cancer Research and Treatment}, publisher={Springer Science and Business Media LLC}, author={Molina, Rafael and Jo, Judith and Filella, Xavier and Zanon, Gabriel and Pahisa, Jaume and Muñoz, Montserrat and Farrus, Blanca and Latre, Maria Luz and Escriche, Carmen and Estape, Jordi and Ballesta, Antonio M.}, year={1998}, month=sep, pages={109–119} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2025,
        6,
        22
      ]
    ],
    "date-time": "2025-06-22T04:02:01Z",
    "timestamp": 1750564921909,
    "version": "3.41.0"
  },
  "reference-count": 28,
  "publisher": "Springer Science and Business Media LLC",
  "issue": "2",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            1998,
            9,
            1
          ]
        ],
        "date-time": "1998-09-01T00:00:00Z",
        "timestamp": 904608000000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "https://www.springernature.com/gp/researchers/text-and-data-mining"
    },
    {
      "start": {
        "date-parts": [
          [
            1998,
            9,
            1
          ]
        ],
        "date-time": "1998-09-01T00:00:00Z",
        "timestamp": 904608000000
      },
      "content-version": "vor",
      "delay-in-days": 0,
      "URL": "https://www.springernature.com/gp/researchers/text-and-data-mining"
    }
  ],
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        1998,
        9
      ]
    ]
  },
  "DOI": "10.1023/a:1005734429304",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2002,
        12,
        21
      ]
    ],
    "date-time": "2002-12-21T23:13:52Z",
    "timestamp": 1040512432000
  },
  "page": "109-119",
  "source": "Crossref",
  "is-referenced-by-count": 86,
  "title": "c-erbB-2 oncoprotein, CEA, and CA 15.3 in patients with breast cancer: prognostic value",
  "prefix": "10.1007",
  "volume": "51",
  "author": [
    {
      "given": "Rafael",
      "family": "Molina",
      "sequence": "first",
      "affiliation": []
    },
    {
      "given": "Judith",
      "family": "Jo",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Xavier",
      "family": "Filella",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Gabriel",
      "family": "Zanon",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Jaume",
      "family": "Pahisa",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Montserrat",
      "family": "Mu\u00f1oz",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Blanca",
      "family": "Farrus",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Maria Luz",
      "family": "Latre",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Carmen",
      "family": "Escriche",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Jordi",
      "family": "Estape",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Antonio M.",
      "family": "Ballesta",
      "sequence": "additional",
      "affiliation": []
    }
  ],
  "member": "297",
  "reference": [
    {
      "key": "125891_CR1",
      "first-page": "651",
      "volume-title": "Protides of the Biological Fluids",
      "author": "J Hilkens",
      "year": "1985",
      "unstructured": "Hilkens J, Kroezen V, Bonfrer JMG, Bruning PF, Hilgers J, van Eijkeren J: A radioimmunoassay for a new antigen (Mam-6) present in the sera of patients with metastasized carcinomas. In: Peeters H (ed) Protides of the Biological Fluids. Pergamon Press, Oxford, 1985, pp 651\u2013653"
    },
    {
      "key": "125891_CR2",
      "doi-asserted-by": "crossref",
      "first-page": "223",
      "DOI": "10.1089/hyb.1984.3.223",
      "volume": "3",
      "author": "D Kufe",
      "year": "1984",
      "unstructured": "Kufe D, Inghirami G, Abe M, Hayes D, Justi-Wheeler H, Schlom J: Differential reactivity of a novel monoclonal antibody (DF-3) with human malignant versus benign breast tumors. Hybridoma 3: 223\u2013232, 1984",
      "journal-title": "Hybridoma"
    },
    {
      "key": "125891_CR3",
      "doi-asserted-by": "crossref",
      "first-page": "1377",
      "DOI": "10.1007/BF01949996",
      "volume": "41",
      "author": "C Stahli",
      "year": "1985",
      "unstructured": "Stahli C, Takacs B, Miggiano V, Stachelin T, Carman H: Monoclonal antibodies against antigens on breast cancer cells. Experientia 41: 1377\u20131381, 1985",
      "journal-title": "Experientia"
    },
    {
      "key": "125891_CR4",
      "doi-asserted-by": "crossref",
      "first-page": "1674",
      "DOI": "10.1002/1097-0142(19891015)64:8<1674::AID-CNCR2820640820>3.0.CO;2-V",
      "volume": "64",
      "author": "R Colomer",
      "year": "1989",
      "unstructured": "Colomer R, Ruibal A, Salvador L: Circulating tumor marker levels in advanced breast carcinoma correlate with the extent of metastatic disease. Cancer 64: 1674\u20131681, 1989",
      "journal-title": "Cancer"
    },
    {
      "key": "125891_CR5",
      "doi-asserted-by": "crossref",
      "first-page": "161",
      "DOI": "10.1007/978-1-4615-3740-3_15",
      "volume-title": "Breast Epithelial Antigens",
      "author": "R Molina",
      "year": "1991",
      "unstructured": "Molina R, Ballesta AM: Evaluation of several tumor markers (MCA, CA 15.3, BCM and CA 549) in tissue and serum of patients with breast cancer. In: Ceriani RL (ed) Breast Epithelial Antigens. Molecular Biology to Clinical Applications, Plenum Press, New York 1991, pp 161\u2013168"
    },
    {
      "key": "125891_CR6",
      "doi-asserted-by": "crossref",
      "first-page": "41",
      "DOI": "10.1007/BF00690183",
      "volume": "36",
      "author": "R Molina",
      "year": "1995",
      "unstructured": "Molina R, Zanon G, Filella X, Moreno F, Jo J, Daniels M, Latre ML, Gimenez N, Pahisa J, Velasco M, Ballesta AM: Use of serial carcinoembryonic antigen and CA 15.3 assays in detecting relapses in breast cancer patients. Breast Cancer Res Treat 36: 41\u201348, 1995",
      "journal-title": "Breast Cancer Res Treat"
    },
    {
      "key": "125891_CR7",
      "doi-asserted-by": "crossref",
      "first-page": "1130",
      "DOI": "10.1126/science.2999974",
      "volume": "230",
      "author": "L Coussens",
      "year": "1985",
      "unstructured": "Coussens L, Yang-Feng TL, Liao YC et al.: Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with the neu oncogene. Science 230: 1130\u20131139, 1985",
      "journal-title": "Science"
    },
    {
      "key": "125891_CR8",
      "first-page": "1965",
      "volume": "12",
      "author": "R Molina",
      "year": "1992",
      "unstructured": "Molina R, Ciocca R, Tandon AK, Allred DC, Clark GC, Chamness GC, Gullick WJ, McGuire WL: Expression of HER-2/neu oncoprotein in human breast cancer. A comparison of immunohistochemical and western blot techniques. Anticancer Res 12: 1965\u20131972, 1992",
      "journal-title": "Anticancer Res"
    },
    {
      "key": "125891_CR9",
      "doi-asserted-by": "crossref",
      "first-page": "707",
      "DOI": "10.1126/science.2470152",
      "volume": "244",
      "author": "DJ Slamon",
      "year": "1989",
      "unstructured": "Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, Ress MF: Studies of the HER-2 neu proto-oncogene in human breast and ovarian cancer. Science 244: 707\u2013712, 1989",
      "journal-title": "Science"
    },
    {
      "key": "125891_CR10",
      "doi-asserted-by": "crossref",
      "first-page": "1120",
      "DOI": "10.1200/JCO.1989.7.8.1120",
      "volume": "7",
      "author": "AK Tandon",
      "year": "1989",
      "unstructured": "Tandon AK, Clark GM, Chamness GC, Ullrich A, McGuire WL: HER-2/neu oncogene protein and prognosis in breast cancer. J Clin Oncol 7: 1120\u20131128, 1989",
      "journal-title": "J Clin Oncol"
    },
    {
      "key": "125891_CR11",
      "doi-asserted-by": "crossref",
      "first-page": "974",
      "DOI": "10.1016/0046-8177(92)90257-4",
      "volume": "23",
      "author": "DC Allred",
      "year": "1992",
      "unstructured": "Allred DC, Clark GM, Molina R, Tandon AK, Schnitt SJ, Gilchrist KW, Osborne CK, Tormey DC, Abeloff MD, McGuire WI: Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer. Human Pathol 23: 974\u2013979, 1992",
      "journal-title": "Human Pathol"
    },
    {
      "key": "125891_CR12",
      "first-page": "1238",
      "volume": "48",
      "author": "MS Berger",
      "year": "1988",
      "unstructured": "Berger MS, Locher GW, Saurer S et al.: Correlation of cerbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res 48: 1238\u20131243, 1988",
      "journal-title": "Cancer Res"
    },
    {
      "key": "125891_CR13",
      "doi-asserted-by": "crossref",
      "first-page": "15",
      "DOI": "10.1007/BF01612634",
      "volume": "116",
      "author": "D Marx",
      "year": "1990",
      "unstructured": "Marx D, Schauer A, Reiche Ch et al.: c-erbB-2 expression in correlation to other biological parameters of breast cancer. J Cancer Res Clin Oncol 116: 15\u201320, 1990",
      "journal-title": "J Cancer Res Clin Oncol"
    },
    {
      "key": "125891_CR14",
      "first-page": "585",
      "volume": "7",
      "author": "R Molina",
      "year": "1993",
      "unstructured": "Molina R, Filella X, Segui MA, Climent MA, Perez-Pica\u00f1ol E, Alonso C, Jo J, Ojeda B, Tandon AK, Ballesta AM: Oncogenic proteins and prognostic correlations in breast cancer. In vivo 7: 585\u2013590, 1993",
      "journal-title": "In vivo"
    },
    {
      "key": "125891_CR15",
      "doi-asserted-by": "crossref",
      "first-page": "599",
      "DOI": "10.1200/JCO.1992.10.4.599",
      "volume": "4",
      "author": "DC Allred",
      "year": "1992",
      "unstructured": "Allred DC, Clark GM, Tandon AK, Molina R, Tormey DC, Osborne CK, Gilchrist KW, Mansour EG, Abeloff MD, McGuire WL: HER-2/neu in node-negative breast cancer: Prognostic significance of overexpression influenced by the presence of in situ carcinoma. J Clin Oncol 4: 599\u2013605, 1992",
      "journal-title": "J Clin Oncol"
    },
    {
      "key": "125891_CR16",
      "doi-asserted-by": "crossref",
      "first-page": "1716",
      "DOI": "10.1016/S0021-9258(18)52354-1",
      "volume": "266",
      "author": "JR Zabrecky",
      "year": "1991",
      "unstructured": "Zabrecky JR, Lam T, McKenzie SJ, Carney W: The extracellular domain of p185 neu is released from the surface of human breast carcinoma cell, SK-BR-3. J Biol Chem 266: 1716\u20131720, 1991",
      "journal-title": "J Biol Chem"
    },
    {
      "key": "125891_CR17",
      "first-page": "2917",
      "volume": "8",
      "author": "SM Pupa",
      "year": "1993",
      "unstructured": "Pupa SM, Menard S, Morelli D, Pozzi B, De Palo G, Colnaghi MI: The extracellular domain of the c-erbB-2 oncoprotein is released from tumor cells by proteolytic cleavage. Oncogene 8: 2917\u20132923, 1993",
      "journal-title": "Oncogene"
    },
    {
      "key": "125891_CR18",
      "doi-asserted-by": "crossref",
      "first-page": "3942",
      "DOI": "10.1002/1097-0142(19930615)71:12<3942::AID-CNCR2820711224>3.0.CO;2-3",
      "volume": "71",
      "author": "SJ McKenzie",
      "year": "1993",
      "unstructured": "McKenzie SJ, De Sombre KA, Bast BS, Hollis DR, Whitaker RS, Berchuck A, Boyer CM, Bast RC: Serum levels of HER-2/neu (C-erbB-2) correlate with overexpression of p184 neu in human ovarian cancer. Cancer 71: 3942\u20133946, 1993",
      "journal-title": "Cancer"
    },
    {
      "key": "125891_CR19",
      "doi-asserted-by": "crossref",
      "first-page": "97",
      "DOI": "10.1007/BF01961242",
      "volume": "24",
      "author": "T Narita",
      "year": "1992",
      "unstructured": "Narita T, Funahashi H, Satoh Y, Takagi H: C-erbB-2 in the sera of breast cancer patients. Breast Cancer Res Treat 24: 97\u2013102, 1992",
      "journal-title": "Breast Cancer Res Treat"
    },
    {
      "key": "125891_CR20",
      "volume-title": "TNM classification of malignant tumours",
      "author": "International Union Against Cancer",
      "year": "1987",
      "unstructured": "International Union Against Cancer (UICC): TNM classification of malignant tumours. In: Hermanek P, Soben LH (eds) 4 ed Springer Verlag, Berlin, 1987",
      "edition": "4 ed"
    },
    {
      "key": "125891_CR21",
      "doi-asserted-by": "crossref",
      "first-page": "188",
      "DOI": "10.1159/000218029",
      "volume": "18",
      "author": "R Molina",
      "year": "1997",
      "unstructured": "Molina R, Jo J, Filella X, Bruix J, Castells A, Hague M, Ballesta AM: Serum levels of c-erbB-2 (HER-2/neu) in patients with malignant and non-malignant diseases. Tumour Biology 18: 188\u2013196, 1997",
      "journal-title": "Tumour Biology"
    },
    {
      "key": "125891_CR22",
      "first-page": "105",
      "volume": "4",
      "author": "DJ Zhou",
      "year": "1989",
      "unstructured": "Zhou DJ, Ahauja H, Cline MJ: Proto-oncogene abnormalities in human breast cancer: c-erbB-2 amplification does not correlate with recurrence of disease. Oncogene 4: 105\u2013108, 1989",
      "journal-title": "Oncogene"
    },
    {
      "key": "125891_CR23",
      "doi-asserted-by": "crossref",
      "first-page": "251",
      "DOI": "10.1093/clinchem/36.2.251",
      "volume": "36",
      "author": "R Molina",
      "year": "1990",
      "unstructured": "Molina R, Filella X, Torres MD, Ballesta AM, Mengual P, Cases A, Balague A: SCC antigen measured in malignant and nonmalignant diseases. Clin Chem 36: 251\u2013254, 1990",
      "journal-title": "Clin Chem"
    },
    {
      "key": "125891_CR24",
      "doi-asserted-by": "crossref",
      "first-page": "1379",
      "DOI": "10.1093/clinchem/37.8.1379",
      "volume": "37",
      "author": "R Molina",
      "year": "1991",
      "unstructured": "Molina R, Filella X, Bruix J, Mengual P, Bosch J, Calvet X, Jo J, Ballesta AM: Cancer antigen 125 in serum and ascitic fluid of patients with liver diseases. Clin Chem 37: 1379\u20131383, 1991",
      "journal-title": "Clin Chem"
    },
    {
      "key": "125891_CR25",
      "first-page": "1379",
      "volume": "37",
      "author": "A Cases",
      "year": "1991",
      "unstructured": "Cases A, Filella X, Molina R, Ballesta AM, Lopez-Revert J, Revert L: Tumor markers in chronic renal failure and hemodialysis patients. Nephron 37: 1379\u20131383, 1991",
      "journal-title": "Nephron"
    },
    {
      "key": "125891_CR26",
      "doi-asserted-by": "crossref",
      "first-page": "339",
      "DOI": "10.1002/ijc.2910330310",
      "volume": "33",
      "author": "RE Ritts Jr",
      "year": "1984",
      "unstructured": "Ritts RE Jr, Del Villano BC, Go VLW, Heberman RB, Klug TL, Zurawski VR Jr: Initial clinical evaluation of an immunoradiometric assay for CA 19.9 using the NCI serum bank. Int J Cancer 33: 339\u2013345, 1984",
      "journal-title": "Int J Cancer"
    },
    {
      "key": "125891_CR27",
      "doi-asserted-by": "crossref",
      "first-page": "1129",
      "DOI": "10.1200/JCO.1995.13.5.1129",
      "volume": "13",
      "author": "K Leitzel",
      "year": "1995",
      "unstructured": "Leitzel K, Teramoto Y, Konrad K, Chinchilli VM, Volas G, Grossberg H, Harvey H, Demers L, Lipton A: Elevated serum c-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer. J Clin Oncol 13: 1129\u20131135, 1995",
      "journal-title": "J Clin Oncol"
    },
    {
      "key": "125891_CR28",
      "doi-asserted-by": "crossref",
      "first-page": "1126",
      "DOI": "10.1038/bjc.1996.501",
      "volume": "74",
      "author": "R Molina",
      "year": "1996",
      "unstructured": "Molina R, Jo J, Zanon G, Filella X, Farrus M, Mu\u00f1oz M, Latre ML, Pahisa J, Velasco M, Fernandez P, Estap\u00e9 J, Ballesta AM: Utility of c-erbB-2 in tissue and in serum in the early diagnosis of recurrence in breast cancer patients: comparisc with carcinoembryonic antigen and CA 15.3. Br J Cancer 74: 1126\u20131131, 1996",
      "journal-title": "Br J Cancer"
    }
  ],
  "container-title": "Breast Cancer Research and Treatment",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1023/A:1005734429304.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1023/A:1005734429304/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.springerlink.com/index/pdf/10.1023/A:1005734429304",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1023/A:1005734429304.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2025,
        6,
        21
      ]
    ],
    "date-time": "2025-06-21T04:32:22Z",
    "timestamp": 1750480342000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://link.springer.com/10.1023/A:1005734429304"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        1998,
        9
      ]
    ]
  },
  "references-count": 28,
  "journal-issue": {
    "issue": "2",
    "published-print": {
      "date-parts": [
        [
          1998,
          9
        ]
      ]
    }
  },
  "alternative-id": [
    "125891"
  ],
  "URL": "http://dx.doi.org/10.1023/A:1005734429304",
  "relation": {},
  "ISSN": [
    "0167-6806",
    "1573-7217"
  ],
  "subject": [],
  "container-title-short": "Breast Cancer Res Treat",
  "published": {
    "date-parts": [
      [
        1998,
        9
      ]
    ]
  }
}